首页> 外国专利> Transgenic Caenorhabditis elegans comprising a human protein with a tendency to aggregate fused to a fluorescent protein

Transgenic Caenorhabditis elegans comprising a human protein with a tendency to aggregate fused to a fluorescent protein

机译:包含人蛋白的转基因秀丽隐杆线虫,具有与荧光蛋白融合的趋势

摘要

The present invention relates to methods and compositions for high content drug screening in Caenorhabditis elegans which may be used to identify compounds that treat disorders associated with protein aggregation. It is based, at least in part, on the discovery that Caenorhabditis elegans, genetically modified to create a model system for disorders of protein aggregation, could be used, in a high throughput screening system, to identify agents that reduce the amount of aggregated protein.
机译:本发明涉及在秀丽隐杆线虫中用于高含量药物筛选的方法和组合物,其可用于鉴定治疗与蛋白质聚集有关的疾病的化合物。它至少部分基于以下发现:经过遗传修饰以创建蛋白质聚集失调模型系统的秀丽隐杆线虫可以在高通量筛选系统中用于鉴定药物减少聚集蛋白的量。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号